Expertise in
4
conditions

Lisa C. Willcocks

Hills Road, 
Cambridge, ENG, GB 
Expertise in
4
conditions
Hills Road, 
Cambridge, ENG, GB 
OverviewLocationsClinical Research

Overview

Lisa Willcocks practices in Cambridge, United Kingdom. Ms. Willcocks is highly rated in 4 conditions, according to our data. Her top areas of expertise are Glomerulonephritis, Vasculitis, IgA Nephropathy, Granulomatosis with Polyangiitis, and Kidney Transplant.

Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Hills Road, Cambridge, ENG CB22QQ, United Kingdom
Other Locations
United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug
Study Drug: BION-1301
Study Phase: Phase 1/Phase 2
A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy
A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy
Enrollment Status: Completed
Publish Date: June 27, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

28 Total Publications

ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition.
ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition.
Journal: Med (New York, N.Y.)
Published: November 19, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Willcocks's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile